Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Lack of hemodynamic effects after extended heme synthesis inhibition by succinylacetone in rats.

Bourque SL, Benjamin CD, Adams MA, Nakatsu K.

J Pharmacol Exp Ther. 2010 Apr;333(1):290-6. doi: 10.1124/jpet.109.162966. Epub 2010 Jan 13.

2.

Screening a panel of drugs with diverse mechanisms of action yields potential therapeutic agents against neuroblastoma.

Gheeya JS, Chen QR, Benjamin CD, Cheuk AT, Tsang P, Chung JY, Metaferia BB, Badgett TC, Johansson P, Wei JS, Hewitt SM, Khan J.

Cancer Biol Ther. 2009 Dec;8(24):2386-95. Epub 2009 Dec 27.

3.

Costimulation and autoimmune diabetes in BB rats.

Beaudette-Zlatanova BC, Whalen B, Zipris D, Yagita H, Rozing J, Groen H, Benjamin CD, Hunig T, Drexhage HA, Ansari MJ, Leif J, Mordes JP, Greiner DL, Sayegh MH, Rossini AA.

Am J Transplant. 2006 May;6(5 Pt 1):894-902.

4.

The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challenge.

Ferrant JL, Benjamin CD, Cutler AH, Kalled SL, Hsu YM, Garber EA, Hess DM, Shapiro RI, Kenyon NS, Harlan DM, Kirk AD, Burkly LC, Taylor FR.

Int Immunol. 2004 Nov;16(11):1583-94. Epub 2004 Oct 5.

PMID:
15466914
5.

Blockade of the CD154-CD40 costimulatory pathway prevents the development of experimental autoimmune glomerulonephritis.

Reynolds J, Khan SB, Allen AR, Benjamin CD, Pusey CD.

Kidney Int. 2004 Oct;66(4):1444-52.

6.

Intragraft gene and protein expression in rat liver allografts treated with costimulatory blockade alone or in combination with CyA.

Bartlett AS, McCall JL, Ameratunga R, Howden B, Ramadas R, Yeong ML, Benjamin CD, Hess D, Munn SR.

J Surg Res. 2003 Nov;115(1):1-8.

PMID:
14572766
7.

Tolerance induction in rats, using a combination of anti-CD154 and donor splenocytes, given once on the day of transplantation.

Sebille F, Brouard S, Petzold T, Degauque N, Guillet M, Moreau A, Benjamin CD, Soulillou JP.

Transplantation. 2003 Jan 27;75(2):169-72.

PMID:
12548117
8.

B lymphocyte memory: role of stromal cell complement and FcgammaRIIB receptors.

Barrington RA, Pozdnyakova O, Zafari MR, Benjamin CD, Carroll MC.

J Exp Med. 2002 Nov 4;196(9):1189-99.

9.

Variation in the ordered structure of complexes between CD154 and anti-CD154 monoclonal antibodies.

Ferrant JL, Wilson CA, Benjamin CD, Hess DM, Hsu YM, Karpusas M, Roux KH, Taylor FR.

Mol Immunol. 2002 Sep;39(1-2):77-84.

PMID:
12213330
10.

CD40 ligand (CD154) does not contribute to lymphocyte-mediated inhibition of virulent Mycobacterium tuberculosis within human monocytes.

Larkin R, Benjamin CD, Hsu YM, Li Q, Zukowski L, Silver RF.

Infect Immun. 2002 Aug;70(8):4716-20.

11.

A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.

Yuan X, Dong VM, Coito AJ, Waaga AM, Salama AD, Benjamin CD, Sayegh MH, Chandraker A.

Transplantation. 2002 Jun 15;73(11):1736-42.

PMID:
12084995
12.

Prolongation of fully allogeneic skin graft survival in the rat by combined administration of costimulatory blockade and sirolimus.

Bartlett AS, McCall JL, Ameratunga R, Yeong ML, Benjamin CD, Peach R, Munn SR.

Transplant Proc. 2002 Jun;34(4):1127-9. No abstract available.

PMID:
12072295
13.

Costimulatory blockade prevents early rejection, promotes lymphocyte apoptosis, and inhibits the upregulation of intragraft interleukin-6 in an orthotopic liver transplant model in the rat.

Bartlett AS, McCall JL, Ameratunga R, Howden B, Yeong ML, Benjamin CD, Hess D, Peach R, Munn SR.

Liver Transpl. 2002 May;8(5):458-68.

14.

Dual role for TWEAK in angiogenic regulation.

Jakubowski A, Browning B, Lukashev M, Sizing I, Thompson JS, Benjamin CD, Hsu YM, Ambrose C, Zheng TS, Burkly LC.

J Cell Sci. 2002 Jan 15;115(Pt 2):267-74.

15.

BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF.

Thompson JS, Bixler SA, Qian F, Vora K, Scott ML, Cachero TG, Hession C, Schneider P, Sizing ID, Mullen C, Strauch K, Zafari M, Benjamin CD, Tschopp J, Browning JL, Ambrose C.

Science. 2001 Sep 14;293(5537):2108-11. Epub 2001 Aug 16.

16.

Anti-CD154 (CD40L) prevents recurrence of diabetes in islet isografts in the DR-BB rat.

Kover KL, Geng Z, Hess DM, Benjamin CD, Moore WV.

Diabetes. 2000 Oct;49(10):1666-70.

PMID:
11016450
17.

BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population.

Thompson JS, Schneider P, Kalled SL, Wang L, Lefevre EA, Cachero TG, MacKay F, Bixler SA, Zafari M, Liu ZY, Woodcock SA, Qian F, Batten M, Madry C, Richard Y, Benjamin CD, Browning JL, Tsapis A, Tschopp J, Ambrose C.

J Exp Med. 2000 Jul 3;192(1):129-35.

18.

Regular articles: conditional disruption of hedgehog signaling pathway defines its critical role in hair development and regeneration.

Wang LC, Liu ZY, Gambardella L, Delacour A, Shapiro R, Yang J, Sizing I, Rayhorn P, Garber EA, Benjamin CD, Williams KP, Taylor FR, Barrandon Y, Ling L, Burkly LC.

J Invest Dermatol. 2000 May;114(5):901-8.

19.

Systematic mutational mapping of sites on human interferon-beta-1a that are important for receptor binding and functional activity.

Runkel L, deDios C, Karpusas M, Betzenhauser M, Muldowney C, Zafari M, Benjamin CD, Miller S, Hochman PS, Whitty A.

Biochemistry. 2000 Mar 14;39(10):2538-51.

PMID:
10704203
20.

Characterization of antihuman IFNAR-1 monoclonal antibodies: epitope localization and functional analysis.

Goldman LA, Zafari M, Cutrone EC, Dang A, Brickelmeier M, Runkel L, Benjamin CD, Ling LE, Langer JA.

J Interferon Cytokine Res. 1999 Jan;19(1):15-26.

PMID:
10048764
21.

Interaction affinity between cytokine receptor components on the cell surface.

Whitty A, Raskin N, Olson DL, Borysenko CW, Ambrose CM, Benjamin CD, Burkly LC.

Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13165-70.

22.

The murine anti-human common gamma chain monoclonal antibody CP.B8 blocks the second step in the formation of the intermediate affinity IL-2 receptor.

Baker DP, Whitty A, Zafari MR, Olson DL, Hession CA, Miatkowski K, Avedissian LS, Foley SF, McKay ML, Benjamin CD, Burkly LC.

Biochemistry. 1998 Oct 13;37(41):14337-49.

PMID:
9772159
23.

Molecular mapping with functional antibodies localizes critical sites on the human IL receptor common gamma (gamma c) chain.

Raskin N, Jakubowski A, Sizing ID, Olson DL, Kalled SL, Hession CA, Benjamin CD, Baker DP, Burkly LC.

J Immunol. 1998 Oct 1;161(7):3474-83.

24.

Antibodies to lymphotoxin alpha (LT alpha) and LT beta recognize different glial cell types in the central nervous system.

Cannella B, Sizing ID, Benjamin CD, Browning JL, Raine CS.

J Neuroimmunol. 1997 Sep;78(1-2):172-9.

PMID:
9307242
25.

Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes.

Mackay F, Bourdon PR, Griffiths DA, Lawton P, Zafari M, Sizing ID, Miatkowski K, Ngam-ek A, Benjamin CD, Hession C, Ambrose CM, Meier W, Browning JL.

J Immunol. 1997 Oct 1;159(7):3299-310.

PMID:
9317128
26.

Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes.

Browning JL, Sizing ID, Lawton P, Bourdon PR, Rennert PD, Majeau GR, Ambrose CM, Hession C, Miatkowski K, Griffiths DA, Ngam-ek A, Meier W, Benjamin CD, Hochman PS.

J Immunol. 1997 Oct 1;159(7):3288-98.

PMID:
9317127
27.

Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines.

Browning JL, Miatkowski K, Sizing I, Griffiths D, Zafari M, Benjamin CD, Meier W, Mackay F.

J Exp Med. 1996 Mar 1;183(3):867-78.

28.

Expression of vascular cell adhesion molecule-1 by follicular dendritic cells.

Huang MJ, Osborn L, Svahn J, Schiffer SB, Eliseo L, Zhou LJ, Rhynhart K, Benjamin CD, Freedman AS.

Leuk Lymphoma. 1995 Jul;18(3-4):259-64.

PMID:
8535191
29.

Human type I interferon receptor, IFNAR, is a heavily glycosylated 120-130 kD membrane protein.

Ling LE, Zafari M, Reardon D, Brickelmeier M, Goelz SE, Benjamin CD.

J Interferon Cytokine Res. 1995 Jan;15(1):55-61.

PMID:
7544230
30.

Are events after endotoxemia related to circulating phospholipase A2?

Santos AA, Browning JL, Scheltinga MR, Lynch EA, Brown EF, Lawton P, Chambers E, Dougas I, Benjamin CD, Dinarello CA, et al.

Ann Surg. 1994 Feb;219(2):183-92.

31.

Alpha 4-integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep.

Abraham WM, Sielczak MW, Ahmed A, Cortes A, Lauredo IT, Kim J, Pepinsky B, Benjamin CD, Leone DR, Lobb RR, et al.

J Clin Invest. 1994 Feb;93(2):776-87.

32.

Arrangement of domains, and amino acid residues required for binding of vascular cell adhesion molecule-1 to its counter-receptor VLA-4 (alpha 4 beta 1).

Osborn L, Vassallo C, Browning BG, Tizard R, Haskard DO, Benjamin CD, Dougas I, Kirchhausen T.

J Cell Biol. 1994 Feb;124(4):601-8.

33.

Expression of vascular cell adhesion molecule-1 in kidney allograft rejection.

Alpers CE, Hudkins KL, Davis CL, Marsh CL, Riches W, McCarty JM, Benjamin CD, Carlos TM, Harlan JM, Lobb R.

Kidney Int. 1993 Oct;44(4):805-16.

34.

Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis.

O'Brien KD, Allen MD, McDonald TO, Chait A, Harlan JM, Fishbein D, McCarty J, Ferguson M, Hudkins K, Benjamin CD, et al.

J Clin Invest. 1993 Aug;92(2):945-51.

35.

Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody.

Podolsky DK, Lobb R, King N, Benjamin CD, Pepinsky B, Sehgal P, deBeaumont M.

J Clin Invest. 1993 Jul;92(1):372-80.

36.

Stimulation of protein tyrosine phosphorylation in human B cells after ligation of the beta 1 integrin VLA-4.

Freedman AS, Rhynhart K, Nojima Y, Svahn J, Eliseo L, Benjamin CD, Morimoto C, Vivier E.

J Immunol. 1993 Mar 1;150(5):1645-52.

PMID:
7679689
37.

Expression of vascular cell adhesion molecule (VCAM-1) in liver and pancreas allograft rejection.

Bacchi CE, Marsh CL, Perkins JD, Carithers RL Jr, McVicar JP, Hudkins KL, Benjamin CD, Harlan JM, Lobb R, Alpers CE.

Am J Pathol. 1993 Feb;142(2):579-91.

38.

Testing coding skills as a pre-employment screening process.

Benjamin CD, Baum BH.

J AHIMA. 1993 Jan;64(1):62-4, 66-8. No abstract available.

PMID:
10124859
40.
41.

The concern for accurate, quality registry data.

Benjamin CD, Watkins S.

J AHIMA. 1992 Mar;63(3):91-4.

PMID:
10118261
42.

Expression and functional characterization of a soluble form of endothelial-leukocyte adhesion molecule 1.

Lobb RR, Chi-Rosso G, Leone DR, Rosa MD, Bixler S, Newman BM, Luhowskyj S, Benjamin CD, Dougas IG, Goelz SE, et al.

J Immunol. 1991 Jul 1;147(1):124-9.

PMID:
1711067
43.

The automated medical record: a practical realization?

Benjamin CD, Baum BH.

Top Health Rec Manage. 1988 Sep;9(1):1-12. No abstract available.

PMID:
10288791
44.

Model approach for a community clinic information system.

Benjamin CD, Miller SC.

Top Health Rec Manage. 1988 Mar;8(3):65-71. No abstract available.

PMID:
10286135
45.

The interface of health care providers, medical records, and prospective payment.

Benjamin CD.

Health Care Superv. 1986 Apr;4(3):32-44. No abstract available.

PMID:
10311469
46.

A convincing case for medical record work stations on patient care floors.

Benjamin CD.

Top Health Rec Manage. 1985 Dec;6(2):41-9. No abstract available.

PMID:
10311362
47.
48.

The design of regulatory circuitry: predominant idiotypy and the idea of regulatory parsimony.

Sercarz EE, Araneo B, Benjamin CD, Harvey M, Metzger D, Miller A, Wicker L, Yowell R.

Ann N Y Acad Sci. 1983;418:198-205. No abstract available.

PMID:
6201103
49.

A predominant idiotype on anti-hen egg white lysozyme antibodies from diverse mouses strains.

Benjamin CD, Miller A, Sercarz EE, Harvey MA.

J Immunol. 1980 Sep;125(3):1017-25.

PMID:
7410825

Supplemental Content

Loading ...
Support Center